杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/24 | 2,015 | 2,020 | 1,995 | 2,008 | -7 | -0.3% | 109,500 |
2020/08/21 | 2,026 | 2,032 | 2,007 | 2,015 | ±0 | ±0% | 109,700 |
2020/08/20 | 2,007 | 2,025 | 2,004 | 2,015 | +3 | +0.1% | 142,100 |
2020/08/19 | 2,001 | 2,020 | 2,000 | 2,012 | +8 | +0.4% | 134,300 |
2020/08/18 | 1,998 | 2,013 | 1,991 | 2,004 | -6 | -0.3% | 118,900 |
2020/08/17 | 2,032 | 2,033 | 2,010 | 2,010 | -20 | -1% | 82,900 |
2020/08/14 | 2,038 | 2,050 | 2,008 | 2,030 | -25 | -1.2% | 163,500 |
2020/08/13 | 2,075 | 2,075 | 2,044 | 2,055 | +17 | +0.8% | 168,400 |
2020/08/12 | 2,001 | 2,043 | 1,999 | 2,038 | +41 | +2.1% | 229,200 |
2020/08/11 | 1,972 | 2,016 | 1,956 | 1,997 | +48 | +2.5% | 197,800 |
2020/08/07 | 1,980 | 1,982 | 1,944 | 1,949 | -23 | -1.2% | 174,300 |
2020/08/06 | 1,955 | 1,981 | 1,946 | 1,972 | -6 | -0.3% | 179,900 |
2020/08/05 | 1,975 | 1,983 | 1,943 | 1,978 | -15 | -0.8% | 206,200 |
2020/08/04 | 2,000 | 2,042 | 1,928 | 1,993 | +18 | +0.9% | 385,800 |
2020/08/03 | 1,962 | 2,030 | 1,940 | 1,975 | +52 | +2.7% | 300,400 |
2020/07/31 | 1,972 | 1,975 | 1,916 | 1,923 | -67 | -3.4% | 303,500 |
2020/07/30 | 1,988 | 2,001 | 1,979 | 1,990 | +1 | +0.1% | 154,300 |
2020/07/29 | 2,002 | 2,009 | 1,982 | 1,989 | ±0 | ±0% | 220,200 |
2020/07/28 | 1,996 | 2,004 | 1,984 | 1,989 | -21 | -1% | 218,200 |
2020/07/27 | 1,970 | 2,010 | 1,969 | 2,010 | +14 | +0.7% | 180,200 |
2020/07/22 | 1,999 | 2,018 | 1,981 | 1,996 | +10 | +0.5% | 191,300 |
2020/07/21 | 1,993 | 2,003 | 1,976 | 1,986 | -30 | -1.5% | 250,300 |
2020/07/20 | 1,993 | 2,016 | 1,980 | 2,016 | +32 | +1.6% | 199,000 |
2020/07/17 | 2,019 | 2,024 | 1,968 | 1,984 | -54 | -2.6% | 363,400 |
2020/07/16 | 2,051 | 2,062 | 2,028 | 2,038 | -51 | -2.4% | 212,700 |
2020/07/15 | 2,101 | 2,130 | 2,082 | 2,089 | -13 | -0.6% | 192,000 |
2020/07/14 | 2,078 | 2,113 | 2,078 | 2,102 | +6 | +0.3% | 98,800 |
2020/07/13 | 2,068 | 2,102 | 2,055 | 2,096 | +40 | +1.9% | 123,500 |
2020/07/10 | 2,068 | 2,078 | 2,054 | 2,056 | +6 | +0.3% | 166,900 |
2020/07/09 | 2,061 | 2,067 | 2,032 | 2,050 | -13 | -0.6% | 136,800 |
2020/07/08 | 2,067 | 2,109 | 2,060 | 2,063 | -4 | -0.2% | 217,500 |
2020/07/07 | 2,104 | 2,104 | 2,033 | 2,067 | -29 | -1.4% | 230,400 |
2020/07/06 | 2,069 | 2,110 | 2,069 | 2,096 | +15 | +0.7% | 118,500 |
2020/07/03 | 2,105 | 2,105 | 2,054 | 2,081 | -11 | -0.5% | 136,900 |
2020/07/02 | 2,138 | 2,147 | 2,076 | 2,092 | -46 | -2.2% | 364,700 |
2020/07/01 | 2,212 | 2,232 | 2,133 | 2,138 | -69 | -3.1% | 174,200 |
2020/06/30 | 2,230 | 2,252 | 2,195 | 2,207 | -11 | -0.5% | 201,900 |
2020/06/29 | 2,171 | 2,234 | 2,171 | 2,218 | +2 | +0.1% | 204,800 |
2020/06/26 | 2,190 | 2,226 | 2,181 | 2,216 | +58 | +2.7% | 267,100 |
2020/06/25 | 2,162 | 2,166 | 2,131 | 2,158 | -42 | -1.9% | 318,000 |
2020/06/24 | 2,228 | 2,231 | 2,198 | 2,200 | -33 | -1.5% | 180,800 |
2020/06/23 | 2,235 | 2,257 | 2,211 | 2,233 | +5 | +0.2% | 250,700 |
2020/06/22 | 2,219 | 2,238 | 2,202 | 2,228 | +34 | +1.5% | 118,400 |
2020/06/19 | 2,181 | 2,202 | 2,160 | 2,194 | +15 | +0.7% | 199,600 |
2020/06/18 | 2,171 | 2,203 | 2,159 | 2,179 | +41 | +1.9% | 225,600 |
2020/06/17 | 2,144 | 2,165 | 2,130 | 2,138 | ±0 | ±0% | 133,100 |
2020/06/16 | 2,120 | 2,150 | 2,113 | 2,138 | +47 | +2.2% | 236,800 |
2020/06/15 | 2,114 | 2,151 | 2,089 | 2,091 | -45 | -2.1% | 115,300 |
2020/06/12 | 2,112 | 2,146 | 2,093 | 2,136 | -12 | -0.6% | 321,700 |
2020/06/11 | 2,148 | 2,157 | 2,116 | 2,148 | -16 | -0.7% | 275,600 |
1151~
1200
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 149,400円 | +8.8% | +99.9% | 3.48% | 9.54倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ジーエヌアイ | 238,200円 | +21.7% | +999.9% | 0.00% | 9.91倍 | 3.28倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 224,700円 | +0.4% | -8.4% | 2.36% | 28.85倍 | 1.63倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 87,900円 | +20.3% | - | 0.00% | 155.03倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム